Adaptive immune responses in the skull bone marrow for CNS immunosurveillance and brain tumor immunity 2247790

J Jang Hyun Park (Washington Univ. Sch. of Med., St. Louis) D Daviti Abramishvili (Washington University in St. Louis) G Gustavo Davanzo (Washington University in St. Louis) R Ruben Silva (Washington University in St. Louis) X Xingxing Gu (Washington University in St. Louis) S Siling Du D Daniel Lee B Bernd Zinselmeyer (Washington University in St. Louis) J Jackson Turner (Department of Pathology and Immunology, Washington University in Saint Louis, School of Medicine) G Gwendalyn Randolph (Washington University in St. Louis) I Igor Smirnov (Washington University in St. Louis) J Jonathan Kipnis (Center for Brain Immunology and Glia, Washington University in St. Louis)

Abstract

Abstract Introduction Mounting evidence indicates that the central nervous system (CNS) maintains active communication with the peripheral immune system, yet the mechanisms by which adaptive immunity monitors the CNS remain incompletely understood. Recent discoveries have revealed specialized vascular and cellular conduits linking the dura mater with the skull, allowing cerebrospinal fluid and immune cell exchange between the CNS and the skull bone marrow (BM) under both steady-state and pathological conditions. Although the skull BM has been recognized as a reservoir of innate immune cells supporting CNS immunity, its contribution to adaptive immune responses has not been thoroughly defined. Methods We analyzed mouse skull bone marrow using single-cell RNA sequencing, flow cytometry, and confocal imaging. Results In this study, we describe organized lymphoid aggregates within the skull BM that display germinal center-like architecture and contain a distinct subset of follicular helper T cells. These T cells drive B cell activation and humoral responses through their communications. We show that adaptive immune cells within these skull BM niches detect and react to CNS-derived antigens and are indispensable for effective antitumor immunity in mouse models of brain cancer. Conclusion Our identification of these specialized adaptive immune hubs in the skull BM establishes a new paradigm for CNS immunosurveillance and unveils therapeutic opportunities for neurological disorders, including malignancies of the brain. Funding Source The ChadTough Foundation Topic Categories Neuroimmunology (NEUR)

Article Details

Volume / Issue Vol. 215, Issue Supplement_1
Published August 01, 2026
ISSN 0022-1767
Publisher American Association of Immunologists

Authors (12)

J

Jang Hyun Park

Washington Univ. Sch. of Med., St. Louis

D

Daviti Abramishvili

Washington University in St. Louis

G

Gustavo Davanzo

Washington University in St. Louis

R

Ruben Silva

Washington University in St. Louis

X

Xingxing Gu

Washington University in St. Louis

S

Siling Du

D

Daniel Lee

B

Bernd Zinselmeyer

Washington University in St. Louis

J

Jackson Turner

Department of Pathology and Immunology, Washington University in Saint Louis, School of Medicine

G

Gwendalyn Randolph

Washington University in St. Louis

I

Igor Smirnov

Washington University in St. Louis

J

Jonathan Kipnis

Center for Brain Immunology and Glia, Washington University in St. Louis